Evaluation of Efficacy and Safety of ATB-1011+ATB-1012 Co-administration for Essential Hypertension and Type II Diabetes

Clinical trial NCT05573477 · UNKNOWN

Trial details

NCT number: NCT05573477
Sponsor: Autotelicbio
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Essential Hypertension Diabetes Mellitus, Type 2

Start date: 2022-11-16
Primary completion: 2024-01-01
Enrollment: 248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.